Company delivered ROE of 12.91% in year ending Mar 31, 2024 outperforming its 5 year avg. of 7.91%. (Source: Consolidated Financials)
Artemis Medicare Services Share Price
Artemis Medicare Servic...
Artemis Medicare share price insights
Company has spent 3.56% of its operating revenues towards interest expenses and 15.81% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Artemis Medicare Services Ltd. share price moved down by -1.72% from its previous close of Rs 268.90. Artemis Medicare Services Ltd. stock last traded price is 264.30
Share Price Value Today/Current/Last 264.30 Previous Day 268.90
Key Metrics
PE Ratio (x) | 64.63 | ||||||||||
EPS - TTM (₹) | 4.09 | ||||||||||
MCap (₹ Cr.) | 3,618.69 | ||||||||||
Sectoral MCap Rank | 17 | ||||||||||
PB Ratio (x) | 8.10 | ||||||||||
Div Yield (%) | 0.17 | ||||||||||
Face Value (₹) | 1.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 266.81 | ||||||||||
52W H/L (₹) |
Artemis Medicare Share Price Returns
1 Day | -1.72% |
1 Week | -1.25% |
1 Month | 1.37% |
3 Months | 48.44% |
1 Year | 115.4% |
3 Years | N.A. |
5 Years | N.A. |
Artemis Medicare News & Analysis
Artemis Medicare Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Artemis Medicare Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Employee & Interest Expense
Company has spent 3.56% of its operating revenues towards interest expenses and 15.81% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 227.61 227.14 220.57 227.43 210.79 Total Income Growth (%) 0.21 2.98 -3.02 7.89 6.64 Total Expenses 197.83 198.33 196.30 200.75 190.81 Total Expenses Growth (%) -0.25 1.03 -2.21 5.21 6.98 EBIT 29.77 28.81 24.27 26.68 19.98 EBIT Growth (%) 3.34 18.73 -9.04 33.51 3.51 Profit after Tax (PAT) 16.67 14.18 11.55 13.59 9.82 PAT Growth (%) 17.54 22.77 -15.03 38.45 -7.35 EBIT Margin (%) 13.08 12.68 11.00 11.73 9.48 Net Profit Margin (%) 7.32 6.24 5.24 5.98 4.66 Basic EPS (₹) 1.14 1.04 0.85 1.00 0.72 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 971.51 904.95 709.66 600.09 586.44 Total Assets Growth (%) 7.36 27.52 18.26 2.33 5.79 Total Liabilities 516.83 497.26 348.40 278.35 272.73 Total Liabilities Growth (%) 3.94 42.73 25.17 2.06 4.52 Total Equity 454.68 407.69 361.26 321.74 313.71 Total Equity Growth (%) 11.53 12.85 12.28 2.56 6.93 Current Ratio (x) 0.98 0.83 0.92 0.92 0.74 Total Debt to Equity (x) 0.67 0.72 0.63 0.34 0.24 Contingent Liabilities 106.89 51.47 77.84 101.62 70.77 All figures in Rs Cr, unless mentioned otherwise
Insights
Decrease in Cash from Investing
Company has used Rs 86.99 cr for investing activities which is an YoY decrease of 45.02%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 108.85 127.16 59.58 27.26 56.08 Net Cash used in Investing Activities -86.99 -158.21 -107.22 -37.42 -26.29 Net Cash flow from Financing Activities -30.12 38.22 44.18 17.72 -27.42 Net Cash Flow -8.26 7.17 -3.46 7.55 2.37 Closing Cash & Cash Equivalent 14.61 22.87 15.70 19.16 11.61 Closing Cash & Cash Equivalent Growth (%) -36.12 45.67 -18.07 65.07 25.65 Total Debt/ CFO (x) 2.33 1.90 3.08 3.95 1.36 All figures in Rs Cr, unless mentioned otherwise
Insights
ROE Outperforming 5 Year Average
Company delivered ROE of 12.91% in year ending Mar 31, 2024 outperforming its 5 year avg. of 7.91%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 12.91 11.49 10.87 2.02 6.31 Return on Capital Employed (%) 12.67 10.05 8.60 3.57 10.13 Return on Assets (%) 5.05 4.26 4.48 1.08 3.37 Interest Coverage Ratio (x) 4.48 5.15 5.96 1.33 3.39 Asset Turnover Ratio (x) 0.94 0.90 0.84 68.05 96.34 Price to Earnings (x) 46.95 23.70 19.12 45.45 9.23 Price to Book (x) 6.06 2.72 2.08 0.92 0.58 EV/EBITDA (x) 17.89 10.94 10.73 9.60 3.69 EBITDA Margin (%) 15.94 13.73 12.86 9.48 11.69
Artemis Medicare Peer Comparison
Artemis Medicare Stock Performance
Ratio Performance
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...- See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Artemis Medicare Board Meeting/AGM
Artemis Medicare Dividends
- Others
Meeting Date Announced on Purpose Details Aug 08, 2024 Aug 01, 2024 Board Meeting Quarterly Results May 10, 2024 May 03, 2024 Board Meeting Audited Results & Final Dividend Apr 05, 2024 Apr 02, 2024 Board Meeting Others Feb 05, 2024 Jan 29, 2024 Board Meeting Quarterly Results Nov 08, 2023 Nov 01, 2023 Board Meeting Quarterly Results Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 45% 0.45 Jul 05, 2024 May 10, 2024 Final 45% 0.45 Jul 14, 2023 May 05, 2023 All Types Ex-Date Record Date Announced on Details Splits Sep 23, 2021 Sep 24, 2021 Aug 05, 2021 Split: Old FV10.0| New FV:1.0
About Artemis Medicare
Artemis Medicare Services Ltd., incorporated in the year 2004, is a Small Cap company (having a market cap of Rs 3,618.69 Crore) operating in Hospitals & Allied Services sector. Artemis Medicare Services Ltd. key Products/Revenue Segments include HealthCare Services, Drugs & Pharmaceuticals, Other Operating Revenue and Scrap for the year ending 31-Mar-2024. Show More
Executives
Auditors
- OK
Onkar Kanwar
Chairman & Non-Exe.DirectorDCDevlina Chakravarty
Managing DirectorNKNeeraj Kanwar
Non Executive DirectorNKNirmal Kumar Ganguly
Non Executive DirectorShow More - T R Chadha & Co. LLPSCV & Co. LLP
Industry
Key Indices Listed on
BSE SmallCap, BSE Healthcare, BSE AllCap, + 1 more
Address
Plot No. 14,Sector 20,Delhi, Delhi - 110075
More Details
FAQs about Artemis Medicare share
- 1. What is Artemis Medicare share price and what are the returns for Artemis Medicare share?Artemis Medicare share price was Rs 264.30 as on 29 Aug, 2024, 03:56 PM IST. Artemis Medicare share price was down by 1.72% based on previous share price of Rs. 272.2.
- 2. What's the market capitalization of Artemis Medicare?Artemis Medicare share has a market capitalization of Rs 3,618.69 Cr. Within Hospitals & Allied Services sector, it's market cap rank is 17.
- 3. What is the CAGR of Artemis Medicare?The CAGR of Artemis Medicare is 21.11.
- 4. What is the PE & PB ratio of Artemis Medicare?The PE ratio of Artemis Medicare stands at 65.76, while the PB ratio is 8.03.
- 5. What are the returns for Artemis Medicare share?Return Performance of Artemis Medicare Shares:
- 1 Week: Artemis Medicare share price moved down by 1.25%
- 3 Month: Artemis Medicare share price moved up by 48.44%
- 6 Month: Artemis Medicare share price moved up by 55.38%
- 6. What are the Artemis Medicare quarterly results?Total Revenue and Earning for Artemis Medicare for the year ending 2024-03-31 was Rs 885.93 Cr and Rs 49.14 Cr on Consolidated basis. Last Quarter 2024-06-30, Artemis Medicare reported an income of Rs 227.61 Cr and profit of Rs 16.67 Cr.
- 7. Is Artemis Medicare giving dividend?Artemis Medicare Services Ltd. announced an equity dividend of 45% on a face value of 1.0 amounting to Rs 0.45 per share on 10 May 2024. The ex dividend date was 05 Jul 2024.
- 8. Who's the owner of Artemis Medicare?Promoter,DII and FII owns 68.03, 1.73 and 0.1 shares of Artemis Medicare as on 30 Jun 2024
- Promoter holding have gone down from 68.03 (31 Mar 2024) to 67.51 (30 Jun 2024)
- Domestic Institutional Investors holding has gone up from 1.73 (31 Mar 2024) to 2.57 (30 Jun 2024)
- Foreign Institutional Investors holding has gone up from 0.1 (31 Mar 2024) to 0.16 (30 Jun 2024)
- Other investor holding have gone down from 30.14 (31 Mar 2024) to 29.76 (30 Jun 2024)
- 9. Who is the chairman of Artemis Medicare?Onkar Kanwar is the Chairman & Non-Exe.Director of Artemis Medicare
- 10. What is Artemis Medicare's 52 week high / low?Artemis Medicare share price saw a 52 week high of Rs 283.95 and 52 week low of Rs 122.40.
- 11. Who are the peers for Artemis Medicare in Hospitals & Allied Services sector?Within Hospitals & Allied Services sector Artemis Medicare, Indraprastha Medical Corporation Ltd., Yatharth Hospital & Trauma Care Services Ltd., Shalby Ltd., Healthcare Global Enterprises Ltd., Kovai Medical Center and Hospital Ltd., Sakar Healthcare Ltd., Lotus Eye Hospital and Institute Ltd., Jupiter Life Line Hospitals Ltd., Rainbow Childrens Medicare Ltd. and Krishna Institute of Medical Sciences Ltd. are usually compared together by investors for analysis.
- 12. How can I quickly analyze Artemis Medicare stock?Key Metrics for Artemis Medicare are:
- PE Ratio of Artemis Medicare is 64.63
- Price/Sales ratio of Artemis Medicare is 2.63
- Price to Book ratio of Artemis Medicare is 8.10
Trending in Markets
Artemis Medicare Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.